Markets:

Overview

News

Currencies

International

Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

54.83 +3.61 (+7.05%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CRISPR Therapeutics AG - Common Shares

< Previous 1 2 3 4 5 6 7 8 9

...

35 36 Next >

Navigating the Future: Unlocking Investment Opportunities in High-Growth Sectors

October 04, 2025

As of October 2025, the global financial markets are undergoing a profound transformation, driven by an accelerating wave of technological innovation and a pressing global imperative for...

Via MarketMinute

10 Health Care Stocks Whale Activity In Today's Session ↗

October 03, 2025

Via Benzinga

How Is The Market Feeling About CRISPR Therapeutics? ↗

September 12, 2025

Via Benzinga

3 Growth Stocks That Could Be 10-Baggers in 10 Years ↗

October 03, 2025

Air taxis, quantum computing, and gene editing are all promising technologies to invest in for the long haul.

Via The Motley Fool

Got $200? 2 Healthcare Stocks to Buy and Hold Forever ↗

October 01, 2025

These stocks could see growth take off over the next few years.

Via The Motley Fool

Could This Beaten-Down Stock Help You Become a Millionaire? ↗

September 30, 2025

The company would need to maintain the strong momentum it's had this year for a long time.

Via The Motley Fool

Topics ETFs

The Pharmaceutical Revolution: AI, Gene Therapies, and Obesity Drugs Reshape a Trillion-Dollar Market

September 19, 2025

The global pharmaceutical sector stands at the precipice of a monumental transformation, driven by an unprecedented convergence of scientific breakthroughs, technological innovation, and evolving...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

My Top Biotech Stock Picks And Portfolio Strategy For The Next 3-10 Years ↗

September 18, 2025

Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds of billions dollars in revenue.

Via Benzinga

Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises

September 18, 2025

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NASDAQ:CRSP),(NASDAQ:BNTX),(NYSE:BMY) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence

Cathie Wood Goes Bargain Hunting: She Just Bought 2 Stocks That Wall Street Thinks Will Climb 50% and 190% ↗

September 11, 2025

These companies are reaching key milestones.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

September 02, 2025

Via Benzinga

1 Reason Every Investor Should Know About CRISPR Therapeutics (CRSP) ↗

August 29, 2025

This little company's scientific breakthrough opened up a whole new sliver of the drug market (although it's still leading the developmental race).

Via The Motley Fool

Peering Into CRISPR Therapeutics's Recent Short Interest ↗

August 22, 2025

Via Benzinga

Cathie Wood's ARKK Is Beating Big Tech Like It's 2020 Again — But With A Twist ↗

August 19, 2025

Cathie Wood's ARK Innovation ETF is outperforming tech market again in 2025, driven by AI breakthroughs and the return of inflows.

Via Benzinga

Topics Artificial Intelligence ETFs

Powering Progress: AI's Insatiable Energy Appetite and Biotech's Dual Dawn

August 27, 2025

The global economy in 2025 is navigating a landscape profoundly reshaped by the escalating demands of Artificial Intelligence (AI) and transformative shifts in healthcare. While the burgeoning energy...

Via MarketMinute

Topics Artificial Intelligence Economy Emissions

Here's How This Forgotten Healthcare Stock Could Generate Life-Changing Returns ↗

August 17, 2025

This biotech's innovative approach could pay rich dividends down the road.

Via The Motley Fool

Cathie Wood's Top 10 Stock Picks: Unpacking Ark Funds Innovation Picks For The Next Decade ↗

August 14, 2025

Ark Invest has six main ETFs with several around for more than 10 years. A look at the top 10 holdings across the six funds and what it could mean.

Via Benzinga

Topics ETFs

Navigating the Currents: Top Sectors Primed for Growth in Q3 2025

August 27, 2025

The global economy is sailing into Q3 2025 with a blend of cautious optimism and persistent challenges. While a new tariff regime and elevated geopolitical tensions introduce elements of uncertainty,...

Via MarketMinute

Topics Artificial Intelligence Economy Retirement

Cathie Wood's Ark Dumps Block Stock Worth $4.8 Million As Bitcoin-Heavy Company Preps Q2 Results ↗

August 05, 2025

Cathie Wood-led Ark Invest executed a significant trade in Block Inc. (NYSE:XYZ) on Tuesday.

Via Benzinga

Up 50% in 3 Months, Is This Stock Still a Buy? ↗

August 05, 2025

This biotech's innovative ways might eventually pay off.

Via The Motley Fool

The 3 Things That Matter for CRISPR Therapeutics Now ↗

July 29, 2025

As time marches on, the factors that could make or break this stock are becoming crystal clear.

Via The Motley Fool

Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics ↗

July 26, 2025

Ark Invest traded in VCYT, IRDM, CRSP, KTOS, ABSI, VEEV, ADPT, and GH. Mainly focused on healthcare innovation.

Via Benzinga

Cathie Wood Doesn't Need Tesla To Win—ARKK Delivers A Blowout While EV Giant Idles ↗

July 25, 2025

During the pandemic-fueled boom of 2020, Cathie Wood's Ark Innovation ETF (NYSE:ARKK) was one of the hottest funds on Wall Street, surging nearly 400% off its March 2020 lows. But that euphoria peaked...

Via Benzinga

Topics ETFs

3 Monster Stocks in the Making to Buy Right Now ↗

July 21, 2025

Via The Motley Fool

Independent Bank Posts Upbeat Earnings, Joins Blaize Holdings, Interactive Brokers Group And Other Big Stocks Moving Higher On Friday ↗

July 18, 2025

U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday.

Via Benzinga

Topics Stocks

3 Monster Stocks to Hold for the Next 10 Years ↗

July 17, 2025

These companies have compelling long-term futures, but the coming decade could prove particularly exciting as each one comes into its own.

Via The Motley Fool

CRISPR Stock Surges in Recent Weeks: What's Going On? ↗

July 10, 2025

Via Benzinga

Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers

July 09, 2025

Via Investor Brand Network

Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers

July 09, 2025

EQNX::TICKER_START (NYSE:CLDI),(NASDAQ:VRTX),(NASDAQ:IBRX),(NASDAQ:CRSP),(NASDAQ:CTMX) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Death

10 Monster Stocks to Hold for the Next 10 Years ↗

July 08, 2025

Each of these 10 businesses offers a market-leading product or service within an industry that's set to explode.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

35 36 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.